Literature DB >> 6436372

Demonstration of the involvement of interleukin 2 in the differentiation of Staphylococcus aureus Cowan I-stimulated B cells.

T Teranishi, T Hirano, B H Lin, K Onoue.   

Abstract

The effect of IL 2 on Staphylococcus aureus Cowan I (SAC)-driven IgG production of human B cells was examined by utilizing chromatographically purified IL 2 (R-IL 2) and the transcription product of the cloned cDNA for human IL 2 purified from recombinant E. coli (G-IL 2). Both preparations of IL 2 by themselves were not enough to induce optimal IgG-production in the SAC-stimulated tonsillar B cell fraction, which was highly enriched for B cells, but effectively induced IgG production in the presence of a subeffective number of T cells or a late-acting B cell differentiation factor (BCDF). In addition, the activity that induced IgG production in the presence of a subeffective number of T cells was absorbed with an IL 2-dependent mouse T cell line. These results clearly indicate that IL 2 has a definite effect on B cell differentiation in this system. Although the mechanisms of this effect remain to be elucidated, a direct effect of IL 2 on B cells may be involved, because the addition of IL 2 along with SAC induced a limited but significant increase of 3H-TdR incorporation in the highly enriched B cell population, which showed very little response to PHA and Con A even in the presence of IL 2, and, as mentioned above, IL 2 induced IgG production in the B cell preparation without any supplement of T cells provided the late-acting BCDF fraction was present in the culture.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6436372

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Production of immunoglobulins by human sIgD+ and sIgD- human blood B lymphocytes in response to stimulation with activated T cells and agonistic antibodies; effect of IL-10, IL-2 and mode of activation of T cells.

Authors:  N R Ling; B Brown; D Hardie
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

2.  Recombinant interleukin 2 and gamma-interferon act synergistically on distinct steps of in vitro terminal human B cell maturation.

Authors:  A S Fauci
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

3.  Interleukin-2 effects on human B cells activated in vivo.

Authors:  T Miyawaki; T Suzuki; J L Butler; M D Cooper
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

4.  Possible role of IL-2 deficiency for hypogammaglobulinaemia in patients with common variable immunodeficiency.

Authors:  J A Rump; A Jahreis; M Schlesier; R Dräger; I Melchers; H H Peter
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

5.  IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablasts.

Authors:  Lucinda J Berglund; Danielle T Avery; Cindy S Ma; Leen Moens; Elissa K Deenick; Jacinta Bustamante; Stephanie Boisson-Dupuis; Melanie Wong; Stephen Adelstein; Peter D Arkwright; Rosa Bacchetta; Liliana Bezrodnik; Harjit Dadi; Chaim M Roifman; David A Fulcher; John B Ziegler; Joanne M Smart; Masao Kobayashi; Capucine Picard; Anne Durandy; Matthew C Cook; Jean-Laurent Casanova; Gulbu Uzel; Stuart G Tangye
Journal:  Blood       Date:  2013-10-24       Impact factor: 22.113

6.  Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2).

Authors:  T Hirano; T Taga; N Nakano; K Yasukawa; S Kashiwamura; K Shimizu; K Nakajima; K H Pyun; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

7.  Enhancement of in vitro and in vivo antigen-specific antibody responses by interleukin 11.

Authors:  T G Yin; P Schendel; Y C Yang
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

8.  Gingival mononuclear cells from chronic inflammatory periodontal tissues produce interleukin (IL)-5 and IL-6 but not IL-2 and IL-4.

Authors:  K Fujihashi; K W Beagley; Y Kono; W K Aicher; M Yamamoto; S DiFabio; J Xu-Amano; J R McGhee; H Kiyono
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

9.  Inhibition of soluble immune response suppressor activity by growth factors.

Authors:  T M Aune
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

10.  C-kinase activity in normal B cells treated with Staphylococcus aureus, Cowan strain I, and phorbol ester: response differences in a patient with prolymphocytic leukaemia.

Authors:  R Cooper; J Louw; J Daniels; D P de Beer; A E Nel
Journal:  Immunology       Date:  1987-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.